KBL MERGER CORP. IV Contracts & Agreements

190 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Separation and Release Agreement dated February 5, 2025, between 180 Life Sciences Corp. and James N. Woody
Separation Agreements
KBL MERGER CORP. IV
Biotechnology
2025
Voting Agreement dated February 5, 2025, between 180 Life Sciences Corp., James N. Woody and Blair Jordan
Voting Agreements
KBL MERGER CORP. IV
Biotechnology
2025
Third Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Third Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2024
Placement Agency Agreement by and between the Company and Maxim Group LLC, dated December 27, 2024
Agency Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2024
Form of Common Stock Purchase Warrant (December 2024 Offering)
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Form of Securities Purchase Agreement
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2024
Offer Letter between 180 Life Science Corp. and Stephen H. Shoemaker (director) dated December 2, 2024 and effective December 3, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Offer Letter between 180 Life Science Corp. and Jay Goodman (director) dated October 25, 2024 and effective October 24, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Form of Warrant to Purchase Shares of Common Stock
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Form of Warrant Inducement Agreement, by and between the Company and Holder
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Financial Advisory Agreement, dated as of October 16, 2024, between A.G.P./Alliance Global Partners and the Company
Advisory Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2024
Asset Purchase Agreement dated September 29, 2024, by and among Elray Resources, Inc., as seller and 180 Life Sciences Corp., as purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2024
Common Stock Purchase Warrant to purchase 3,000,000 shares of common stock dated September 30, 2024, granted by 180 Life Sciences Corp. to Elray Resources, Inc
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2024
Separation and Release Agreement dated September 5, 2024 and First Amendment to Separation and Release Agreement dated September 5, 2024, by and between Cannbiorex Pharma Ltd.,...
Separation Agreements
KBL MERGER CORP. IV
Biotechnology
CA
2024
Indemnity Agreement dated September 3, 2024 and effective September 5, 2024, between 180 Life Sciences Corp. and Sir Marc Feldmann
KBL MERGER CORP. IV
Biotechnology
DE
2024
Separation and Release Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. James N. Woody
Separation Agreements
KBL MERGER CORP. IV
Biotechnology
CA
2024
Separation and Release Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Jonathan Rothbard
Separation Agreements
KBL MERGER CORP. IV
Biotechnology
CA
2024
Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Jonathan Rothbard
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2024
Fourth Amendment to Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. and Dr. Lawrence Steinman
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Executive Consulting Agreement dated May 7, 2024, by and between 180 Life Sciences Corp. , Blair Jordan and Blair Jordan Strategy and Finance Consulting Inc
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2024
Form of 180 Life Sciences Corp. Indemnity Agreement
KBL MERGER CORP. IV
Biotechnology
DE
2024
Offer Letter between 180 Life Science Corp. and Omar Jimenez (director) dated March 4, 2024 and effective March 7, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Offer Letter between 180 Life Science Corp. and Ryan L. Smith (director) dated March 5, 2024 and effective March 7, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Offer Letter between 180 Life Science Corp. and Blair Jordan (director) dated February 24, 2024 and effective February 28, 2024
KBL MERGER CORP. IV
Biotechnology
2024
Second Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Second Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2024
Fourth Amendment to Employment Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Fourth Amendment to Employment Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Third Amendment to Consulting Agreement dated January 10, 2024 and effective as of January 1, 2024, between 180 Life Sciences Corp. and Lawrence Steinman, M.D
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Second Amendment to Consulting Agreement dated January 10, 2024 and effective as of January 1, 2024, between Cannbiorex Pharma Ltd. and Sir Marc Feldmann
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
2024
Form of Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Warrant Amendment Agreement, dated November 28, 2023, by and between the Company and the Purchaser
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Amendment No.1 to the Securities Purchase Agreement, dated November 28, 2023, by and between 180 Life Sciences Corp. and the Purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
2023
180 Life Sciences Corp. Policy for the Recovery of Erroneously Awarded Incentive-Based Compensation
Compensation Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2023
Termination Letter (Oxford License) September 22, 2023
Termination Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Form of Stock Option Agreement (First Amended and Restated 2022 Omnibus Incentive Plan)
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2023
Placement Agency Agreement, dated August 9, 2023, by and between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners
Agency Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants, dated August 14, 2023, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Warrant Amendment Agreement, dated August 9, 2023, by and between the Company and Armistice Capital Master Fund Ltd
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Securities Purchase Agreement dated August 9, 2023, by and between 180 Life Sciences Corp. and the Institutional Investor
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Warrant Agent Agreement for Pre-Funded Warrants and Common Warrants
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
First Amendment to 180 Life Sciences Corp. 2022 Omnibus Incentive Plan
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
2023
First Amended and Restated 180 Life Sciences Corp. 2022 Omnibus Incentive Plan
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2023
Form of Placement Agent Agreement
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Pre-Funded Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Common Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Securities Purchase Agreement
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2023
Amendment No. 1 to Common Stock Purchase Warrant between 180 Life Sciences Corp. and the warrant holder, dated April 5, 2023
Stock Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Amended and Corrected Third Amendment to Employment Agreement dated May 9, 2023, between 180 Life Sciences Corp. and Ozan Pamir
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2023
Amendment No. 1 to the Warrants, dated April 5, 2023, by and between 180 Life Sciences Corp. and the Selling Stockholder
KBL MERGER CORP. IV
Biotechnology
2023
Warrant Agent Agreement for the July 2022 Common Warrants, dated July 29, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and Ozan Pamir
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2023
Third Amendment to Employment Agreement dated April 27, 2023 and effective as of January 1, 2023, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Placement Agent Agreement, dated April 5, 2023, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Pre-Funded Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Common Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Securities Purchase Agreement, dated April 5, 2023, by and between 180 Life Sciences Corp. and the Purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Warrant Agent Agreement for Pre-Funded Warrants, dated April 10, 2023 by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Warrant Agent Agreement for Common Warrants, dated April 10, 2023 by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2023
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2023
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
KBL MERGER CORP. IV
Biotechnology
DE
2023
First Amendment to Separation and Release Agreement, dated March 29, 2023, by and between 180 Life Sciences Corp. and Quan Vu
Separation Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Separation and Release Agreement, dated January 18, 2023, by and between 180 Life Sciences Corp. and Quan Vu
Separation Agreements
KBL MERGER CORP. IV
Biotechnology
CA
2023
Amendment to the Warrant Agent Agreement, dated January 13, 2023, by and between 180 Life Sciences Corp. and the Warrant Agent
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Warrant Amendment, dated January 12, 2023, by and between 180 Life Sciences Corp. and the Purchaser
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2023
Third Amendment to Consulting Agreement dated December 28, 2022, between 180 Life Sciences Corp., Cannbiorex Pharma Ltd. and Prof. Jagdeep Nanchahal
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
2022
Placement Agent Agreement, dated December 20, 2022, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Pre-Funded Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Common Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Securities Purchase Agreement, dated December 20, 2022, by and between 180 Life Sciences Corp. and the Purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Warrant Agent Agreement for the Pre-Funded Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Warrant Agent Agreement for the Common Warrants, dated December 22, 2022, by and between 180 Life Sciences Corp. and Continental Stock Transfer & Trust Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2022
Placement Agent Agreement dated July 17, 2022, between 180 Life Sciences Corp. and A.G.P./Alliance Global Partners
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Pre-Funded Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Common Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Securities Purchase Agreement dated July 17, 2022, by and between 180 Life Sciences Corp. and the Purchaser
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2022
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2022
180 Life Sciences Corp. 2022 Omnibus Incentive Plan
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2022
Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2022
Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Quan Anh Vu
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2022
Second Amendment to Employment Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2022
Second Amendment to Consulting Agreement dated May 26, 2022 and effective as of June 1, 2022, between 180 Life Sciences Corp. and Lawrence Steinman, M.D
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
2022
First Amendment to Amended and Restated Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and James N. Woody, M.D., Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2022
First Amendment to Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Quan Anh Vu
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2022
First Amendment to Employment Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Jonathan Rothbard, Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2022
First Amendment to Employment Agreement dated April 27, 2022, between Cannbiorex Pharma Ltd. and Sir Marc Feldmann, Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2022
First Amendment to Consulting Agreement dated April 27, 2022, between 180 Life Sciences Corp. and Lawrence Steinman, M.D
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
2022
Second Amendment to Consulting Agreement dated April 27, 2022, between Cannbiorex Pharma Ltd. and Prof. Jagdeep Nanchahal
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
2022
Consulting Agreement dated November 17, 2021, by and between 180 Life Science Corp. and Lawrence Steinman, M.D
Consulting Agreements
KBL MERGER CORP. IV
Biotechnology
CA
2021
Employment Agreement dated October 29, 2021, by and between 180 Life Sciences Corp. and Quan Anh Vu
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
CA
2021
Debt Conversion Agreement dated September 30, 2021, by and between 180 Life Sciences Corp. and Dr. Lawrence Steinman and Sir Marc Feldmann
KBL MERGER CORP. IV
Biotechnology
DE
2021
Settlement and Mutual Release Agreement dated September 17, 2021, by and between 180 Life Sciences Corp. and Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C
Settlement Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
Form of Purchaser Warrant (August 2021 Offering)
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Securities Purchase Agreement dated as of August 19, 2021 by and between 180 Life Sciences Corp. and the purchasers identified on the signature pages thereto
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2021
Engagement Letter dated August 17, 2021 between 180 Life Sciences Corp. and Maxim Group LLC
KBL MERGER CORP. IV
Biotechnology
NY
2021
Registration Rights Agreement dated as of August 23, 2021 by and between 180 Life Sciences Corp. and the purchasers signatory thereto
Registration Rights Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Form of Lock-Up Agreement (August 2021 Offering)
KBL MERGER CORP. IV
Biotechnology
2021
Form of Stock Option Agreement (Independent Directors August 2021 Grants)
Stock Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
Common Stock Purchase Warrant dated July 31, 2021, to purchase 25,000 shares of common stock of 180 Life Sciences Corp., granted to Alpha Capital Anstalt
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Mutual Release and Settlement Agreement dated July 31, 2021, issued by 180 Life Sciences Corp. to Alpha Capital Anstalt
Settlement Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Sir Marc Feldmann Confirmation of Rescission of Note Amendments effective February 25, 2021
Note Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Dr. Lawrence Steinman Confirmation of Rescission of Note Amendments effective February 25, 2021
Note Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934, as amended
KBL MERGER CORP. IV
Biotechnology
DE
2021
Form of August 21, 2019 Employment Agreement between KBL Merger Corp. IV and Jonathan Rothbard
Merger Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
Form of Director Nominee Offer Letter (May 2021)
KBL MERGER CORP. IV
Biotechnology
2021
Second Amendment to Employment Agreement dated May 27, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp., Katexco Pharmaceuticals Corp. and Ozan Pamir
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
Settlement and Mutual Release Agreement dated May 4, 2021, by and between 180 Life Sciences Corp. and EarlyBirdCapital, Inc
Settlement Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
First Amendment to Consultancy Agreement dated March 31, 2021, by and between 180 Life Sciences Corp. and Prof Jagdeep Nanchahal
KBL MERGER CORP. IV
Biotechnology
2021
Consultancy Agreement dated February 22, 2021, by and between 180 Life Sciences Corp. and Prof Jagdeep Nanchahal
KBL MERGER CORP. IV
Biotechnology
2021
Amended and Restated Employment Agreement dated February 25, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp. and James N. Woody
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
CA
2021
James N. Woody - Stock Option Agreement effective February 26, 2021 (1,400,000 shares)
Stock Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
Employment Agreement dated February 24, 2021, and effective November 6, 2020, by and between 180 Life Sciences Corp. and Ozan Pamir and Amendment and Correction Thereto dated...
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
Ozan Pamir - Stock Option Agreement effective February 26, 2021 (180,000 shares)
Stock Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2021
Form of Warrant
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Securities Purchase Agreement dated as of February 19, 2021 by and between 180 Life Sciences Corp. and the purchasers identified on the signature pages thereto
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2021
Engagement Letter dated January 26, 2021 between 180 Life Sciences Corp. and Maxim Group LLC
KBL MERGER CORP. IV
Biotechnology
NY
2021
Amendment to Engagement Letter between 180 Life Sciences Corp. and Maxim Group LLC dated February 18, 2021
KBL MERGER CORP. IV
Biotechnology
2021
Registration Rights Agreement dated as of February 23, 2021 by and between 180 Life Sciences Corp. and the purchasers signatory thereto
Registration Rights Agreements
KBL MERGER CORP. IV
Biotechnology
2021
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2021
Amendment Agreement dated November 25, 2020
KBL MERGER CORP. IV
Biotechnology
2020
Form of Lock-Up Agreement
KBL MERGER CORP. IV
Biotechnology
2020
Escrow Agreement dated November 6, 2020 by and between the registrant, Continental Stock Transfer & Trust Company, and Lawrence Pemble
Escrow Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2020
2020 Omnibus Incentive Plan
Bonus & Incentive Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2020
Employment Agreement, dated July 1, 2020 by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2020
First Amendment to Employment Agreement by and between 180 Life Corp. (f/k/a 180 Life Sciences Corp.) and James N. Woody, M.D., Ph.D
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
2020
Amended and Restated Promissory Note, dated September2020, issued to KBL IV Sponsor LLC
Note Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2020
Convertible Promissory Note, dated September2020, issued to KBL IV Sponsor LLC
Note Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2020
Form of 10% Senior Secured Convertible Promissory Note
Note Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2020
Securities Purchase Agreement, dated September 8, 2020, by and among the Company and the purchasers signatory thereto
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2020
Registration Rights Agreement, dated September 8, 2020, by and among the Company and the parties signatory thereto
Registration Rights Agreements
KBL MERGER CORP. IV
Biotechnology
2020
Amendment No. 2 to Business Combination Agreement, dated as of August 7, 2020, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder...
Merger Agreements
KBL MERGER CORP. IV
Biotechnology
2020
Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock of the Company
Stock Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2020
Form of 10% Senior Secured Convertible Promissory Note
Note Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2020
Securities Purchase Agreement, dated June 12, 2020, by and among the Company and the purchasers signatory thereto
Purchase Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2020
Registration Rights Agreement, dated June 12, 2020, by and among the Company and the parties signatory thereto
Registration Rights Agreements
KBL MERGER CORP. IV
Biotechnology
2020
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
KBL MERGER CORP. IV
Biotechnology
DE
2020
Amendment No. 1 to Business Combination Agreement, dated as of January 29, 2020, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder...
Merger Agreements
KBL MERGER CORP. IV
Biotechnology
2020
Promissory Note, dated March 15, 2019 issued to KBL IV Sponsor LLC
Note Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2019
Promissory Note, dated August 21, 2019 issued to CannBioRx Life Sciences Corp
Note Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2019
Promissory Note, dated August 28, 2019 issued to CannBioRx Life Sciences Corp
Note Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2019
Promissory Note, dated September 30, 2019 issued to CannBioRx Life Sciences Corp
Note Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2019
Form of Support Agreement, by and between KBL and certain stockholders of the Company
KBL MERGER CORP. IV
Biotechnology
DE
2019
Form of Lock-Up Agreement, by and between KBL and certain stockholders of the Company
KBL MERGER CORP. IV
Biotechnology
2019
Form of Tyche Backstop Agreement
KBL MERGER CORP. IV
Biotechnology
2019
Employment Agreement, dated as of July 23, 2019, by and between KBL and Marlene Krauss
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2019
Employment Agreement, dated as of July 23, 2019, by and between KBL and George Hornig
Employment Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2019
Business Combination Agreement, dated as of July 25, 2019, by and among KBL, the Company, Katexco, CBR Pharma, 180, Merger Sub and the Stockholder Representative
Merger Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2019
Underwriting Agreement between the Company and the representatives of the several underwriters set forth therein
Underwriting Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
Warrant Agreement, dated June 1, 2017, between Continental Stock Transfer & Trust Company and the Company
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
Investment Management Trust Account Agreement, dated June 1, 2017, between Continental Stock Transfer & Trust Company and the Company
Management Agreements
KBL MERGER CORP. IV
Biotechnology
2017
Rights Agreement, dated June 1, 2017, between the Company and Continental Stock Transfer & Trust Company
KBL MERGER CORP. IV
Biotechnology
NY
2017
Registration Rights Agreement among the Company and certain securityholders
Registration Rights Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2017
Letter Agreement by and between the Company and its officers and directors and certain securityholders
KBL MERGER CORP. IV
Biotechnology
2017
Third Amended and Restated Unit Subscription Agreement, dated June 1, 2017 between the Company and KBL IV Sponsor LLC
Subscription Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
Third Amended and Restated Unit Subscription Agreement, dated June 1, 2017 between the Company and the underwriters of the IPO
Subscription Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
Administrative Services Agreement, dated June 1, 2017, between the Company and KBL IV Sponsor LLC
Services Agreements
KBL MERGER CORP. IV
Biotechnology
2017
UNDERWRITINGAGREEMENT between KBLMERGER CORP. IV and LADENBURGTHALMANN & CO. INC., B.RILEY & CO. LLC, FBRCAPITAL MARKETS & CO., and I-BANKERSSECURITIES INC. Dated:[______], 2017
KBL MERGER CORP. IV
Biotechnology
NY
2017
SECOND AMENDEDAND RESTATED UNIT SUBSCRIPTION AGREEMENT
Subscription Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
KBLMERGER CORP. IV UNITSCONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASEONE SHARE OF COMMON STOCK
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2017
[Form of Warrant Certificate] [FACE]
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2017
WARRANT AGREEMENT
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
KBLMERGER CORP. IV INCORPORATEDUNDER THE LAWS OF DELAWARE RIGHT
KBL MERGER CORP. IV
Biotechnology
2017
RIGHTSAGREEMENT
KBL MERGER CORP. IV
Biotechnology
NY
2017
[Signaturepage follows]
KBL MERGER CORP. IV
Biotechnology
2017
INVESTMENTMANAGEMENT TRUST AGREEMENT
Investment Agreements
KBL MERGER CORP. IV
Biotechnology
2017
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2017
SECONDAMENDED AND RESTATED UNIT SUBSCRIPTION AGREEMENT
Subscription Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
UNDERWRITINGAGREEMENT between KBLMERGER CORP. IV and LADENBURGTHALMANN & CO. INC., B.RILEY & CO. LLC and FBRCAPITAL MARKETS & CO. Dated:[______], 2017
KBL MERGER CORP. IV
Biotechnology
NY
2017
[Signaturepage follows]
KBL MERGER CORP. IV
Biotechnology
2017
AMENDEDAND RESTATED UNIT SUBSCRIPTION AGREEMENT
Subscription Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
UNDERWRITINGAGREEMENT between KBLMERGER CORP. IV and LADENBURGTHALMANN & CO. INC., B.RILEY & CO. LLC and FBRCAPITAL MARKETS & CO. Dated:[______], 2017
KBL MERGER CORP. IV
Biotechnology
NY
2017
INVESTMENTMANAGEMENT TRUST AGREEMENT
Investment Agreements
KBL MERGER CORP. IV
Biotechnology
2017
UNITSUBSCRIPTION AGREEMENT
KBL MERGER CORP. IV
Biotechnology
NY
2017
KBLMERGER CORP. IV UNITSCONSISTING OF ONE SHARE OF COMMON STOCK AND ONE WARRANT TO PURCHASEONE SHARE OF COMMON STOCK
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2017
KBLMERGER CORP. IV INCORPORATEDUNDER THE LAWS OF THE STATE OF DELAWARE COMMONSTOCK
KBL MERGER CORP. IV
Biotechnology
2017
[Form of Warrant Certificate] [FACE]
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
2017
WARRANT AGREEMENT
Warrant Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
PROMISSORYNOTE
KBL MERGER CORP. IV
Biotechnology
2017
[Signaturepage follows]
KBL MERGER CORP. IV
Biotechnology
2017
INVESTMENTMANAGEMENT TRUST AGREEMENT
Investment Agreements
KBL MERGER CORP. IV
Biotechnology
2017
REGISTRATIONRIGHTS AGREEMENT
Registration Rights Agreements
KBL MERGER CORP. IV
Biotechnology
DE
2017
KBL Merger Corp. IV 150 West 56th Street New York, NY 10019 September7, 2016
KBL MERGER CORP. IV
Biotechnology
NY
2017
UNITSUBSCRIPTION AGREEMENT
KBL MERGER CORP. IV
Biotechnology
NY
2017
AMENDED AND RESTATED UNIT SUBSCRIPTION AGREEMENT
Subscription Agreements
KBL MERGER CORP. IV
Biotechnology
NY
2017
INDEMNITYAGREEMENT
KBL MERGER CORP. IV
Biotechnology
DE
2017
KBLMerger Corp. IV 527 Stanton Christiana Rd. Newark,DE 19713
KBL MERGER CORP. IV
Biotechnology
2017